Potassium aspartate
- Generic Name
- Potassium aspartate
- Drug Type
- Small Molecule
- Chemical Formula
- C8H14K2N2O9
- CAS Number
- 7259-25-8
- Unique Ingredient Identifier
- OC4598NZEQ
Overview
No overview information available.
Background
No background information available.
Indication
1.治疗低钾血症：各种原因引起的低钾血症，如进食不足、呕吐、严重腹泻、应用排钾利尿药、低钾性家族性周期性麻痹、长期应用糖皮质激素和补充高渗葡萄糖等；2.预防低钾血症：但患者存在失钾情况，尤其是如果发生低钾血症对患者危害较大时（如洋地黄化的患者），需要预防性补充钾盐，如进食很少、严重或慢性腹泻、长期服用肾上腺皮质激素、失钾性肾病等；3.洋地黄中毒引起频发、多源性早搏或快速性心律失常。
Associated Conditions
- Hyperammonaemia
- Hypokalemia
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|
No clinical trials found
No clinical trials found for this drug
FDA Approved Products
Product Name | Manufacturer | Route | Strength | Approved | NDC Code |
|---|
No FDA products found
No FDA products found for this drug
EMA Approved Products
Medicine Name | EMA Number | Auth. Holder | Country | Drug Type | Status | Issued | Opinion | Revision |
|---|
No EMA products found
No EMA products found for this drug
HSA Approved Products
Product Name | Manufacturer | Dosage Form | Strength | Approved | Approval No. |
|---|---|---|---|---|---|
SOLUTION | 1.2g/5ml | 2003/03/17 | SIN12230P | ||
INFUSION, SOLUTION | 3.581g/1000ml | 2018/01/23 | SIN15411P |
NMPA Approved Products
Product Name | Approval No. | Manufacturer | Dosage Form | Trade Name | Strength | Type | Status | Date | Import |
|---|---|---|---|---|---|---|---|---|---|
国药准字H20243591 | 注射剂 | N/A | 10ml：门冬氨酸钾1.712g（按C₄H₆KNO₄计） | Chemical Drug | Approved | 2024/04/24 | Domestic | ||
国药准字H20193165 | 注射剂 | N/A | 10ml:门冬氨酸钾1.712g(K+:10mEq) | Chemical Drug | Approved | 2019/06/06 | Domestic | ||
国药准字H20133001 | 注射剂 | N/A | 20ml:门冬氨酸钾3.424g | Chemical Drug | Approved | 2021/01/07 | Domestic | ||
国药准字H20249698 | 注射剂 | N/A | 10ml：门冬氨酸钾1.712g（按C₄H₆KNO₄计） | Chemical Drug | Approved | 2024/12/06 | Domestic | ||
国药准字H20183435 | 注射剂 | N/A | 10ml：门冬氨酸钾1.712g（按C₄H₆KNO₄计） | Chemical Drug | Approved | 2023/10/18 | Domestic | ||
国药准字H20163416 | 注射剂 | N/A | 20ml:门冬氨酸钾3.424g(K＋:20mEq) | Chemical Drug | Approved | 2020/04/14 | Domestic | ||
国药准字H20244837 | 注射剂 | N/A | 10ml：门冬氨酸钾1.712g（按C₄H₆KNO₄计） | Chemical Drug | Approved | 2024/09/10 | Domestic | ||
国药准字H20244774 | 注射剂 | N/A | 10ml:门冬氨酸钾1.712g（按C₄H₆KNO₄计） | Chemical Drug | Approved | 2024/09/03 | Domestic | ||
国药准字H20244775 | 注射剂 | N/A | 20ml:门冬氨酸钾3.424g（按C₄H₆KNO₄ 计 | Chemical Drug | Approved | 2024/09/03 | Domestic | ||
国药准字H20150024 | 注射剂 | N/A | 10ml:门冬氨酸钾1.712g(K＋:10mEq) | Chemical Drug | Approved | 2020/04/14 | Domestic |
PPB Approved Products
Product Name | Registration Code | Company | Category | Sale Type | Reg. Date |
|---|
No PPB products found
No PPB products found for this drug
TGA Approved Products
Product Name | ARTG ID | Sponsor | Status | Reg. Date | Ingredient |
|---|---|---|---|---|---|
305454 | Active | 2018/06/27 | potassium aspartate | ||
95172 | Advanced Medicine Australia Pty Ltd | Active | 2003/06/24 | potassium aspartate | |
216265 | Active | 2013/10/21 | potassium aspartate | ||
284603 | Active | 2017/01/13 | potassium aspartate | ||
392691 | Active | 2022/07/25 | potassium aspartate | ||
305455 | Active | 2018/06/27 | potassium aspartate | ||
401154 | Active | 2022/12/15 | potassium aspartate | ||
399770 | Active | 2022/11/22 | potassium aspartate | ||
229301 | Active | 2014/10/14 | potassium aspartate | ||
463465 | Active | 2024/10/01 | potassium aspartate |
© Copyright 2025. All Rights Reserved by MedPath